av/teklalife-sciences-investors--big.svg

NYSE:HQL

Tekla Life Sciences Investors

  • Stock

USD

Last Close

15.38

26/07 20:00

Market Cap

397.95M

Beta: 0.83

Volume Today

79.75K

Avg: 77.50K

Dividend Yield

9.13%

Payout:62.47%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '13
Sep '14
Sep '15
Sep '16
Sep '17
Sep '18
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23
revenue
520K
-
880K
69.23%
1.32M
50.30%
1.44M
8.67%
69.81M
4,757.42%
29.82M
57.28%
-69.34M
332.52%
124.08M
278.94%
65.69M
47.06%
-103.25M
257.18%
23.52M
122.78%
cost of revenue
3.10M
-
4.14M
33.55%
5.65M
36.42%
4.55M
19.45%
4.61M
1.33%
4.77M
3.52%
5.00M
4.86%
5.21M
4.05%
6.08M
16.71%
5.55M
8.67%
5.24M
5.49%
gross profit
-2.58M
-
-3.26M
26.36%
-4.33M
32.67%
-3.11M
28.05%
65.20M
2,195.29%
25.05M
61.58%
-74.35M
396.79%
118.88M
259.90%
59.61M
49.85%
-108.80M
282.51%
18.28M
116.80%
selling and marketing expenses
general and administrative expenses
440K
-
370K
15.91%
253.60K
31.46%
549.50K
116.68%
991.51K
80.44%
880.76K
11.17%
876.76K
0.45%
751.32K
14.31%
844.02K
12.34%
1.08M
27.57%
903.14K
16.12%
selling general and administrative expenses
440K
-
370K
15.91%
253.60K
31.46%
549.50K
116.68%
991.51K
80.44%
880.76K
11.17%
876.76K
0.45%
751.32K
14.31%
844.02K
12.34%
1.08M
27.57%
903.14K
16.12%
research and development expenses
other expenses
150.00K
-
130K
13.33%
143.44K
10.34%
129.31K
9.85%
423.33K
227.37%
466.64K
10.23%
259.76K
44.33%
278.66K
7.28%
313.69K
12.57%
275.97K
12.02%
-11.79M
4,371.19%
cost and expenses
3.69M
-
4.64M
25.75%
6.04M
30.28%
5.23M
13.52%
5.56M
6.37%
5.59M
0.58%
1.14M
79.68%
1.03M
9.37%
1.16M
12.40%
1.35M
16.84%
1.17M
13.40%
operating expenses
590.00K
-
500K
15.25%
397.04K
20.59%
678.81K
70.97%
1.26M
84.98%
1.16M
7.83%
1.14M
1.80%
1.03M
9.37%
1.16M
12.40%
1.35M
16.84%
1.17M
13.40%
interest expense
87.82M
-
93.03M
5.93%
45.22M
51.39%
-8.12M
117.96%
72.43M
991.94%
32.27M
55.45%
ebitda
172.47M
-
182.30M
5.70%
85.72M
52.98%
-20.03M
123.37%
140.99M
803.80%
60.94M
56.78%
-70.48M
215.66%
123.05M
274.60%
64.53M
47.56%
-104.60M
262.10%
22.35M
121.37%
operating income
-3.17M
-
-3.77M
18.93%
-4.72M
25.26%
-3.79M
19.73%
-3.88M
2.32%
-3.61M
7.00%
-70.48M
1,853.88%
123.05M
274.60%
64.53M
47.56%
-104.60M
262.10%
22.35M
121.37%
depreciation and amortization
175.64M
-
186.07M
5.94%
90.44M
51.39%
-16.24M
117.96%
144.87M
991.94%
64.54M
55.45%
2.88M
95.54%
2.11M
26.55%
4.14M
95.73%
2.99M
27.76%
total other income expenses net
87.82M
-
93.04M
5.94%
45.22M
51.40%
-8.12M
117.96%
72.43M
991.94%
32.27M
55.45%
-4.69K
100.01%
-11.18K
138.48%
-7.84K
29.90%
2.42K
130.88%
-1.70K
170.33%
income before tax
84.65M
-
89.27M
5.46%
40.50M
54.63%
-11.91M
129.41%
68.56M
675.54%
28.66M
58.19%
-70.48M
345.88%
123.05M
274.60%
64.53M
47.56%
-104.60M
262.10%
22.35M
121.37%
income tax expense
3
-
1
66.67%
-2.88M
288,372,700%
-2.13M
26.28%
-4.15M
95.07%
-2.99M
27.95%
net income
84.65M
-
89.27M
5.46%
40.50M
54.63%
-11.91M
129.41%
68.56M
675.54%
28.66M
58.19%
-70.48M
345.88%
123.05M
274.60%
64.53M
47.56%
-104.60M
262.10%
22.35M
121.37%
weighted average shs out
14.99M
-
19.01M
26.79%
19.69M
3.58%
20.74M
5.37%
21.36M
2.96%
22.41M
4.91%
23.18M
3.45%
23.85M
2.88%
24.26M
1.73%
25.68M
5.85%
26.79M
4.33%
weighted average shs out dil
14.99M
-
19.01M
26.82%
19.69M
3.56%
20.74M
5.37%
21.36M
2.96%
23.30M
9.12%
23.18M
0.53%
23.85M
2.88%
24.26M
1.73%
25.68M
5.85%
26.79M
4.33%
eps
5.65
-
4.70
16.81%
2.06
56.17%
-0.57
127.67%
3.21
663.16%
1.28
60.12%
-3.04
337.50%
5.16
269.74%
2.66
48.45%
-4.07
253.01%
0.83
120.39%
epsdiluted
5.65
-
4.70
16.81%
2.06
56.17%
-0.57
127.67%
3.21
663.16%
1.23
61.68%
-3.04
347.15%
5.16
269.74%
2.66
48.45%
-4.07
253.01%
0.83
120.39%

All numbers in USD (except ratios and percentages)